Lecap Asset Management Ltd. Grows Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

Lecap Asset Management Ltd. lifted its position in Doximity, Inc. (NASDAQ:DOCS) by 235.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 38,940 shares of the company’s stock after buying an additional 27,341 shares during the period. Lecap Asset Management Ltd.’s holdings in Doximity were worth $2,079,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. UMB Bank n.a. boosted its stake in Doximity by 69.1% in the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after acquiring an additional 235 shares in the last quarter. Farther Finance Advisors LLC lifted its holdings in shares of Doximity by 324.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock valued at $34,000 after purchasing an additional 603 shares during the last quarter. Morse Asset Management Inc purchased a new stake in shares of Doximity during the 3rd quarter valued at $46,000. GAMMA Investing LLC boosted its position in shares of Doximity by 40.1% in the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after purchasing an additional 412 shares in the last quarter. Finally, Covestor Ltd grew its stake in Doximity by 441.9% during the 3rd quarter. Covestor Ltd now owns 1,680 shares of the company’s stock worth $73,000 after buying an additional 1,370 shares during the last quarter. Institutional investors own 87.19% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on DOCS. Needham & Company LLC upped their target price on Doximity from $65.00 to $82.00 and gave the company a “buy” rating in a research report on Friday. Truist Financial upped their target price on Doximity from $35.00 to $49.00 and gave the company a “hold” rating in a research report on Thursday, November 14th. Morgan Stanley raised Doximity from an “underweight” rating to an “equal weight” rating and upped their target price for the company from $33.00 to $53.00 in a research report on Thursday, November 14th. Canaccord Genuity Group lowered Doximity from a “buy” rating to a “hold” rating and upped their target price for the company from $40.00 to $60.00 in a research report on Wednesday, November 13th. Finally, Raymond James reaffirmed an “outperform” rating and set a $65.00 target price (up from $37.00) on shares of Doximity in a research report on Friday, November 8th. Twelve investment analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $59.12.

Doximity Stock Up 0.7 %

Shares of DOCS opened at $58.58 on Friday. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $61.75. The company has a market capitalization of $10.94 billion, a price-to-earnings ratio of 67.33, a PEG ratio of 4.68 and a beta of 1.39. The stock’s 50-day moving average price is $55.09 and its 200-day moving average price is $45.31.

Doximity (NASDAQ:DOCS) last issued its earnings results on Thursday, November 7th. The company reported $0.24 EPS for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.02). Doximity had a return on equity of 19.79% and a net margin of 33.69%. The company had revenue of $136.83 million during the quarter, compared to analysts’ expectations of $127.05 million. During the same quarter in the previous year, the company earned $0.18 EPS. As a group, equities analysts anticipate that Doximity, Inc. will post 0.88 EPS for the current fiscal year.

Insiders Place Their Bets

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the transaction, the director now owns 6,360 shares in the company, valued at approximately $366,463.20. This represents a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 37.40% of the stock is currently owned by company insiders.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.